{"id":"https://openalex.org/W44482172","doi":null,"title":"Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.","display_name":"Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W44482172","mag":"44482172","pmid":"https://pubmed.ncbi.nlm.nih.gov/8500237"},"language":"en","primary_location":{"id":"pmid:8500237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8500237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102834247","display_name":"Gary R. Johnson","orcid":"https://orcid.org/0000-0002-0169-2155","observed_orcids":["https://orcid.org/0000-0002-0169-2155"]},"institutions":[{"id":"https://openalex.org/I4405286586","display_name":"West Haven Cooperative Studies Program Coordinating Center","ror":"https://ror.org/02jgrq374","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210086971","https://openalex.org/I4210095851","https://openalex.org/I4405286586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Johnson","raw_affiliation_strings":["Cooperative Studies Program Coordinating Center, VA Medical Center, West Haven, Conn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cooperative Studies Program Coordinating Center, VA Medical Center, West Haven, Conn","institution_ids":["https://openalex.org/I4405286586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039697719","display_name":"Peter E. Carson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Carson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113737774","display_name":"G. S. FRANCIS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G S Francis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109315387","display_name":"Cohn Jn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J N Cohn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6248,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.6864277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"87","issue":"6 Suppl","first_page":"VI32","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":0.9779999852180481},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.8100000023841858},{"id":"https://openalex.org/keywords/ventricular-arrhythmias","display_name":"ventricular arrhythmias","score":0.8550000190734863},{"id":"https://openalex.org/keywords/plasma-norepinephrine","display_name":"plasma norepinephrine","score":0.8790000081062317},{"id":"https://openalex.org/keywords/plasma-renin","display_name":"plasma renin","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cardiothoracic-ratio","display_name":"cardiothoracic ratio","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nyha-functional-class","display_name":"NYHA functional class","score":0.8949999809265137},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5989999771118164},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.5640000104904175},{"id":"https://openalex.org/keywords/vasodilator-therapy","display_name":"vasodilator therapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/treatment-response-subgroups","display_name":"treatment response subgroups","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9435737729072571},{"id":"https://openalex.org/C2778949068","wikidata":"https://www.wikidata.org/wiki/Q179748","display_name":"Isosorbide dinitrate","level":2,"score":0.9130693078041077},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.8652392029762268},{"id":"https://openalex.org/C2780521442","wikidata":"https://www.wikidata.org/wiki/Q419987","display_name":"Hydralazine","level":3,"score":0.781166672706604},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7254262566566467},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6880700588226318},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.643052875995636},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.4419432580471039},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.17647194862365723},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.16536787152290344}],"mesh":[{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004656","descriptor_name":"Enalapril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006830","descriptor_name":"Hydralazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007548","descriptor_name":"Isosorbide Dinitrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8500237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8500237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"},{"id":"mag:44482172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8500237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046383587","https://openalex.org/W2237992867","https://openalex.org/W2411929984","https://openalex.org/W4231837928","https://openalex.org/W4213088461","https://openalex.org/W2394830540","https://openalex.org/W3043424092","https://openalex.org/W2407847255","https://openalex.org/W2008912910","https://openalex.org/W2409009582"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"effects":[2],"of":[3,12,31,51,56,61,95,169,177,247,265],"hydralazine":[4,57],"plus":[5,58],"isosorbide":[6,62],"dinitrate":[7,63,186,214,305],"were":[8,44,87,105,174,245],"compared":[9,183],"with":[10,69,110,116,132,184,190,200,229,251,272,295,303],"those":[11],"enalapril":[13,52,70,205,296],"in":[14,28,72,77,108,114,130,153,155,187,198,215,217,224,249],"804":[15],"men":[16],"receiving":[17],"digoxin":[18],"and":[19,97,125,145,152,163,171,197,221,223,260,285],"diuretic":[20],"therapy":[21],"for":[22,282],"chronic":[23],"congestive":[24],"heart":[25],"failure":[26],"(CHF)":[27],"the":[29,81,241,293,301],"Department":[30],"Veterans":[32],"Affairs":[33],"Cooperative":[34],"Vasodilator-Heart":[35],"Failure":[36],"Trial":[37],"(V-HeFT":[38],"II).":[39],"METHODS":[40],"AND":[41],"RESULTS:":[42],"Patients":[43],"randomly":[45],"assigned":[46],"to":[47,80,89,101],"receive":[48],"20":[49],"mg":[50,55,60],"or":[53,149,194,228,231],"300":[54],"160":[59],"daily.":[64],"At":[65],"2":[66],"years,":[67],"treatment":[68,271,275,297],"resulted":[71],"a":[73,142,274],"significant":[74],"(28%)":[75],"reduction":[76],"mortality":[78,96,181,211,248,294,302],"relative":[79,99],"active":[82],"control":[83],"treatment.":[84,102,306],"Baseline":[85],"variables":[86],"examined":[88],"determine":[90],"their":[91],"impact":[92],"on":[93,98,141],"risk":[94],"response":[100],"Mortality":[103],"rates":[104],"significantly":[106,182,207,298],"higher":[107,299],"patients":[109,115,131,154,199,216,225,250,266],"severe":[111],"ventricular":[112,235],"arrhythmias;":[113],"low":[117,121,126,201],"baseline":[118],"ejection":[119],"fractions,":[120],"peak":[122],"oxygen":[123],"consumption,":[124],"systolic":[127],"blood":[128],"pressures;":[129],"high":[133,136,146,191],"cardiothoracic":[134,202,256],"ratios,":[135,257],"scores":[137],"indicating":[138],"greater":[139,208],"impairment":[140],"quality-of-life":[143],"questionnaire,":[144],"plasma":[147,192,283],"norepinephrine":[148,195,284],"renin":[150,193],"levels;":[151],"New":[156],"York":[157],"Heart":[158],"Association":[159],"(NYHA)":[160],"classes":[161,219],"III":[162],"IV.":[164],"Coronary":[165],"artery":[166],"disease,":[167],"duration":[168],"CHF,":[170,252],"patient":[172,188,290],"age":[173],"not":[175],"predictive":[176,246],"mortality.":[178],"Enalapril":[179],"reduced":[180],"hydralazine/isosorbide":[185,213,304],"subgroups":[189,264],"levels":[196],"ratios.":[203],"Furthermore,":[204],"conferred":[206],"protection":[209],"from":[210,270],"than":[212,300],"NYHA":[218,261,286],"I":[220],"II":[222],"without":[226],"arrhythmias":[227],"<":[230],"=":[232],"10":[233],"premature":[234],"contractions":[236],"per":[237],"hour.":[238],"CONCLUSIONS:":[239],"Of":[240],"prerandomization":[242],"characteristics":[243],"that":[244],"only":[253,281],"neurohormone":[254],"measurements,":[255],"arrhythmia":[258],"severity,":[259],"class":[262],"identified":[263],"who":[267],"benefited":[268],"most":[269],"enalapril;":[273],"interaction":[276],"across":[277],"strata":[278],"was":[279,292],"detected":[280],"class.":[287],"In":[288],"no":[289],"subgroup":[291]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}